Egyptian-viva

Login
Course Content
BASIC PHARMACOLOGY
0/4
dr sayed pharmacodynamics
58:16
dr sayed pharmacokinetics
58:16
Dr Marwa part 1 pharmacokinetics
01:24:35
Dr Marwa part 2 Pharmacodynamic
01:44:14
ANESTHESIA PHARMACOLOGY
0/7
Opioids
48:16
Dr Abdalla Induction agents
01:05:37
Dr Ibrahim Opioids
48:16
Dr Marwa Opioids
01:27:10
Dr Marwa Inhational drugs
01:39:07
Dr Marwa local anaesthetic drugs
23:29
MR,LA,anticholinesterases, antimuscarinics
01:28:29
NON-ANESTHESIA PHARMACOLOGY
0/15
dr alaa- anticholinergics
08:46
dr alaa- new antidiabetic drugs- weight loss medications
25:04
dr alaa- NSAIDS
15:19
DR alaa – dexmedetomidine
20:41
dr alaa- levosemindane
20:41
Dr Ibrahim Uterus, kidney, anticoagulant, antiplatelet
28:18
Dr Ibrahim antidepressants, antiepileptic
13:04
Dr Marwa preoperative drug management
01:36:53
Dr Marwa Antiplatelets &Anticoagulants
01:56:11
Dr Marwa Nsaids
17:05
Dr Marwa Antiepileptic drugs
30:37
Dr Marwa antiarrythmic antihypertensive drugs
01:46:11
Dr Marwa antidepressants and lithium
38:51
Dr Marwa Antidiuretics
26:50
Dr Marwa Antiemetics
32:28
pharmacology2026
0/20
Dr Marwa corticosteroids
33:07
Dr Marwa CNS stimulants drugs
29:41
Dr Marwa Antipsychotic drugs
33:11
Dr Marwa Antiparkinson drugs
34:41
Dr Abdalla pharmacokinetics, pharmacodynamics
01:42:52
D Marwa insulin pharmacology
40:41
D Marwa oral hypoglycemic drugs
28:17
D Marwa Drugs acting on thyroid gland
23:34
Dr sayed analgesics 1 inflammatory mediators
00:00
Dr sayed analgesics 2
10:18
Dr sayed analgesics 3
Dr sayed analgesics 4
00:00
Dr sayed analgesics 5
00:00
Dr Ibrahim, IV vs Inhalation anesthetic agents
27:13
Dr Ibrahim, Gas partition coefficient
10:48
Dr Ibrahim, Molecular & Neuronal targets of General anesthetics
11:31
Dr Ibrahim, impact of Volatile anesthetics agent on environment, Succinylcholine
23:40
Dr Ibrahim, benzodiazepin MOA, Toxicity
17:32
Dr Ibrahim, neuromuscular Reversal agents (Neostigmine & sugammadex
14:50
Dr Ibrahim, Local anesthetics
12:45
D-EDAIC PART 2 EXAM PREPARATION COURSE (PHARMACOLOGY MODULE)
Join the conversation
Previous
Next
0% Complete